Laura M. Periman, MD; and Pedram Hamrah, MD
Show Description +
Laura Periman, MD, welcomes Tufts University professor, Pedram Hamrah, MD, to discuss his recent clinical paper reviewing patients with neuropathic corneal pain and their response to low-dose naltrexone. In the first part of this two-part interview, Dr. Hamrah examines the leading causes of centralized neuropathic pain, such as anxiety, depression, and small fiber neuropathy.
REFERENCES
Dieckmann G, Ozmen MC, Cox SM, Engert RC, Hamrah P. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. Ocul Surf. 2021 Apr;20:33-38. doi: 10.1016/j.jtos.2020.12.003. Epub 2021 Jan 12. PMID: 33450415.
Posted: 8/27/2021
Laura M. Periman, MD; and Pedram Hamrah, MD
Laura Periman, MD, welcomes Tufts University professor, Pedram Hamrah, MD, to discuss his recent clinical paper reviewing patients with neuropathic corneal pain and their response to low-dose naltrexone. In the first part of this two-part interview, Dr. Hamrah examines the leading causes of centralized neuropathic pain, such as anxiety, depression, and small fiber neuropathy.
REFERENCES
Dieckmann G, Ozmen MC, Cox SM, Engert RC, Hamrah P. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain. Ocul Surf. 2021 Apr;20:33-38. doi: 10.1016/j.jtos.2020.12.003. Epub 2021 Jan 12. PMID: 33450415.
Posted: 8/27/2021
Please log in to leave a comment.